AbbVie Inc. (NYSE:ABBV)
Bands
Volume
200 SMA
50 SMA
20 SMA
Videos
Alerts
Articles
Events
Old Forum Content for ABBV
Make a Forum Post Become a member to view recent forum posts. Already a member? Sign in here.
- Mikev200: $ACN $ABT $ABBV nice moves on volume
- phgruver: $ABBV is still running, and pulling $XLV with it. @DavidK: $BA, no, $WFC, yes, $CLF, no. Financials, in gerneral ($XLF) are working, but the other two are in the dog house. Will they recover? Sooner or later, but, in the mean time, there are better places to put your money.
- DavidK: @phgruver $ABBV $XLV $BA $WFC $CLF $XLF $CLF- yep this along with other steel stocks seem to be signally a slowdown in the economy . I will be picking up some clf sometime but that’s the big question , when ? Chart looks like down to 10 . Company had been buying back stock but maybe needs to conserve the cash now .
- phgruver: Healthcare $XLV, and utilities, $XLU are my best performers, so far today. In healthcare I have $ABBV, $BMY, $CVS and $PFE. I would suggest you stay away from $PFE, but the others are cooking! In utilities I have $AEP, $D, $DUK and $SO. I'm not real happy with $D, but the others all have nice charts and pay decent dividends. $AEP, $DUK and $SO are all breaking out from a squeeze and are above the upper Bollinger Band.
- woodman: @phgruver $XLV $XLU $ABBV $BMY $CVS $PFE $AEP $D $DUK $SO - Some additional sectors, perhaps: XLRE, SDY, maybe IHI (but nearing rising resistance), and maybe XLF & GLD/IAU (they are resting today)
- phgruver: @DavidG $PFE Man, I could write a whole blog post about that! Let me try to put it succintly, though. First, $PFE is an established player in a difficult sector with a wide moat to their business. The FDA is a major obstacle to any newcomer! So, ...
- jaeran: @woodman $XLV $XLU $ABBV $BMY $CVS $PFE $AEP $D $DUK $SO
-
StockMarketMentor: ...
$ABBV -- stopped out for a 10.7% gain. Good trade, but momentum is slowing, and the stock is starting to roll over. I'm protecting profits here.
$RYTM -- stopped out at 46.49. Holding at the 50-day moving average. I'm closing this on the ATI l ... - StockMarketMentor: $ABBV -- Raising the suggested stop to 194.10 to lock in a 10.4% gain. The uptrend remains strong, but I don't want to risk allowing a good trade to turn into a not-so-good trade. --Dan
-
StockMarketMentor: ...
Currently $ABBV is the only one that’s active ($PFE got stopped out yesterday for a small loss). I will likely put a few stocks on today to capitalize on any continuation of yesterday’s buying.
Watch for it on Telegram, in the Tradin ... - phgruver: @Henry $UNH I'm in $ABBV, which is also flying high! As it looks right now, healthcare isn't going to be the political football of choice, this election cycle, so it may be "safe" to invest in $XLV components.
- Mikev200: $ABBV green
- Mikev200: $ABBV ATH
-
StockMarketMentor: ...
$ABBV: Down a bit and still in consolidation. We were faked out by the breakout above $175 last week, but the stock is stable and seems to just need more time.
$BAC: Looking for a floor at $42 to complete the second phase of a volatility squeeze ... - phgruver: While I like $ABBV long term, be careful with it RHRN. Earnings will be reported Thur., before the bell. The chart pattern is "constructive", but it is running along the upper Bollinger Band. The relatively close proximity of the price to the 50dma and 200dma is a positive. Also, the dividend, at 3.6%, is attractive but not overwelmingly so.
-
StockMarketMentor: ...
$ABBV wanted to break out yesterday and I want to start a position here. I’ll make it conditional on breaking above yesterday’s intraday high of 175.74, and a stop just below yesterday’s low of 169.51.
$JNJ is on a tear and is ... - wjj3: @StockMarketMentor $XLF $XLV $BAC $PFE $ABBV $JNJ $ $GEHC upward price action is
- Wolf: $ABBV Up 3% on Cowen upgrade and Sionna news. NP
- Wolf: $ABBV Receives Positive CHMP Opinion for Epcoritamab (TEPKINLY®) for the Treatment of Adults with Relapsed/Refractory Follicular Lymphoma. Up 2% on 3.5% normal volume.
- Wolf: $ABBV Broke through a choppy trendline and is back above all the moving averages. Watching for a further breakout or the 50DMA to hold. Long with 170 covered call.
- Wolf: $ABBV Continuing to breakout. May have to roll cc again.
- Wolf: $ABBV IRA #Bottom-Fishing Buy-write stock 160 06/28 STO160 call @ 3.79. BTC today @ 2.08.
- Wolf: $ABBV making a dragonfly off the 200DMA. NP.
- indigo1948: @DAN $ADBE - Dan - good morning. Could you cover $ABBV, $SANM, $DOCU and $CLF. Thank you.
- indigo1948: @DAN - Please look at $PLTR, $CL, $TOL, $ABBV & $SANM. Thank you.
- phgruver: @woodman $LLY $ABBV, $LLY and $MRK are certainly driving $XLV higher!
- Mikev200: $ABBV ATH
- phgruver: @Mikev200 $ABBV I wish I had more, but I can't buy it here.
- BarryC: Hi Everyone!! Hope ya had a great weekend!! If anyone cares, I'm currently #Long: $ABBV, $BX, $GTLB, $IBIT, $MRVL, $MSOS, $NVO, $PATH, $PSTG, $$XBI
- BarryC: Hi Everyone!! Hope all is good in the hood :-) Im currently $Long: $ABBV, $BX, $GTLB, $IBIT, $MRVL, $MSOS, $NVO, $PATH & $PSTG... I'm still staring at $XBI in particular.... Have a great day!!
- BarryC: Hi Everyone!! GM!! I put on a couple new positions yesterday and mentioned them here as I did them... I'm currently #Long: $ABBV, $BX, $EYPT, $GTLB, $IBIT, $MRVL, $MSOS, $NVO & $XBI... #FWIW: I keep hearing that "breath is bad" and as a result we're "overbought"... FOR ME, I will stick to the prices (Charts) and that's ALL I NEED! Anything else is an opinion and we know what they say about those... :-) Stick to ur plan & Lets kick some axx!!
- BarryC: Hi everyone, I'm still pretty light overall... I'm currently #long: $ABBV, $EYPT, $GTLB, $MSOS, & $NVO... I did buy a small starter position in $XBI yesterday afternoon and its my main focus today... Lets kick some axx!! :-)
- BarryC: Hi guys, Im still pretty light... Im currently #Long: $ABBV, $EYPT, $GTLB, $MSOS & $NVO
- phgruver: @BarryC $ABBV $EYPT $GTLB $MSOS $NVO #Long I like $ABBV as a LT hold, but I couldn't buy it RHRN. It pays a 3.62% dividend (at $171.26), and has had a really good run since the first of Dec. I'm long from $68.... :-)
- phgruver: @BarryC $ABBV $EYPT $GTLB $MSOS $NVO #Long I like $ABBV as a LT hold, but I couldn't buy it RHRN. It pays a 3.62% dividend (at $171.26), and has had a really good run since the first of Dec. I'm long from $68, so my rate of return is over 9%..... :-)
- BarryC: Hi Everyone, Hope ya had a great weekend!! I'm fairly light overall and currently #Long: $ABBV, $EYPT, $JNUG, $MSOS, $NVO, $RSP & $XHB As always, I will post anything I do as I go :-)
- BarryC: I bot $ABBV
- indigo1948: @BarryC $ABBV - longer term hold for me = peaks and valleys - now a slight peak.
- Boone.ruth: @BarryC $ABBV thanks for this one
- BarryC: @Boone.ruth $ABBV :-) <3
- woodman: $ABBV @BarryC - ABBV For Skyrizi & Rinvoq, combined 2027 revenues are now expected to be >$27B, ~$6B increase vs previous guidance. for Ubrelvy & Qulipta, combined peak revenue is expected to be >$3B, an increase of ~$1B compared to previous guidance.
- BarryC: $ABBV Worth Watching
- BarryC: $ABBV earnings tomorrow, my bad!!!
- joelsg1: $EOLS Up after strong E, half the price of Botox for those who inject neurotoxins, so pure play alternative to $ABBV which owns Botox, Np.
- phgruver: @oldtimer The only thing green for me was $ABBV. Just now $IBM also went green. That really isn't telling me anything, other than this is a really tough market....
- phgruver: I'm not seeing much to do, today, but one thing of note: If $PFE holds yesterday's low of $28.27, this may be a good place to add in a LT account. $BMY also looks good right here for an income producing portfolio. Both of these are lagging their peers $ABBV, $GSK, $LLY & $MRK, so I expect them to play catch up.
- Wolf: $ABBV Broke out yesterday on 2x normal volume. Up slightly today. Started a small position.
- Wolf: @Onthemark $PFE $ABBV is breaking out as well. Tagged the upper BB on decent volume. No position.
- Wolf: $ABBV Back above all MA's. Took a small position @ 151.63. Not a real good entry, but it continues to move higher on higher than average volume.
- Wolf: $ABBV Clean break through the 200 DMA and so far not looking back.
- phgruver: Possible bounce play with $PFE. The dividend is $0.41/qtr, which equates to 5.67% at this price. Unless you expect $PFE to totally collapse, this is a pretty good #VALUE entry for a solid income in a long term portfolio. $XLV, in general, is down near lows, although $LLY and $NOV seems to be bucking that trend. (I also own $ABBV and $BMY for income)
- Wolf: $ABBV Looking kind of frisky on news they are buying ImmunoGen....
- woodman: @dmurphy68 $ARDX - I agree with that too. For illustration purposes, $IMGN went from a $3.70 stock in April this year to $29 yesterday on an announced buyout by $ABBV for over $10 billion. It's a bit of apples and oragnes (IMGN focuses on antibody-drug conjugate (ADC) technology to treat cancer), I know, but $ARDX is a $1 Billion company right now. If ARDX is bought, IMO, it will be for much more than current price and even that $9 price.
- dmurphy68: @woodman $ARDX $IMGN $ABBV $29 would be a very welcome development. I would not be disappointed (or surprised, really) if it went for even half that.
- woodman: $XBI continues up. All my little Bios are working today. Has the worm finally turned for biotech (we'll see at the overhead 200d, I suppose)? $IMGN deal (bought by $ABBV for $10 billion) is helping today.
- sgiseller: $ABBV anyone tracking this? Looks to have a big pipeline but has been taken to the woodshed this year
- traderbren: #Shorts - closed out my $UNH short this morning, but still holding my $ABBV short -- both via Puts.
- wjj3: $ABBV triple bottom at 132 ish and break thru resistance at 140 looking then for 160 with 4.4% pretty fair risk reward
- phgruver: Healthcare, $XLV, is holding support and showing promise. All my healthcare stocks, $ABBV, $BMY, $CVS, $PFE are looking good right here.
- phgruver: I like the way $XLV is setting up on the daily chart. It's above the 200dma, holding support at the 50dma and trading just above the lower Bolenger Band. To me, it looks poised to move higher over the next couple of weeks. $XLV has nearly 20% of it's assets in $UNH and $JNJ, and another 5% in each of $LLY, $ABBV, $PFE and $ABT. Not surprisingly, all those underlying stocks have charts that look pretty similar. I own several stock in this space, (which I don't trade) and use options on $XLV to add to my returns. Many of these stock are good dividend payers, which pay well in the long term, if you get good entries.
- lauralynnee: $ABBV is approaching within a few points of ATH, 50/200 cross a few days back, had made nice run up and has settled down and sitting on 8EMA. Could be making a handle on the massive cup...
-
Rockstar: ...
The $DIA and $IWM continue their strength with some strength in more than a couple ETF's. The ETF's that I am looking at long positions include $TAN, $XLF, $XLE, $XLB, $XLI, $XLP, $XLV, $XME,and $IYT. Of these, I am hesitant on the $XLE with oi ... -
Rockstar: ...
Specific stocks I am looking at for longs are in the health care sector with $JNJ,$ABBV,$VRTX,$MRK,$CI and $UNH on that list. I am also looking at $PEP $COST,$WMT, $TMUS (already long), $NUE $GS and $AXP for longs in the $XLV and $XLF sectors. ... - phgruver: @vcondry $LLY Healthcare, $XLV, in general is getting hammered. $BMY is my biggest looser, today, but $ABBV, $CVS, and $PFE are all down biggly. I can't find any news either, but there was a big run up going into the election, so maybe just a bit of profit taking, although down 4% to 5% seems a bit extreme for basic profit taking.....
- vcondry: @phgruver $LLY $XLV $BMY $ABBV $CVS $PFE did find a report that early this morning some fake verified Twitter accounts including one for Lilly that was not legit said "Insulin is now Free" which got spread everywhere causing a big hit but other then that yes it seems pretty excessive for $JNJ $LLY etc Like I said its been a pretty decent buying opportunity before but who knows.
- traderbren: $ABBV - we could see a gap fill trade with a move above 149. Long from below.
- phgruver: $ABBV is trading down $7 (about 5%) after being downgraded by SVB Leerink. Actually, it wasn't a downgrade, but a lowering of their price target to $135. Consequently, $ABBV is now trading just above that lowered $135 price target. Earnings continue to be good, and the $5.64 dividend appears to be safe. With a P/E of 19.97, the stock would appear to be fairly valued. Not a screaming buy RHRN, but one to watch for a long term investment. At the current price, the dividend yield is right at 4%, what Cramer calls "an accidental high yielder." If the price stabilizes right here, it could be a strategic buy.
- phgruver: @traderbren $LLY Right now, in health care/pharma, ($XLV) I'm holding $ABBV, $BMY, $CVS and $PFE. All are doing OK, but I couldn't recommend buying or adding RHRN. Everything seems to be under pressure. Time to go do something else. It's a waste of time to sit here watching the market flounder.
- bwcarnation1: @scottrades $VRTX $ABBV holding up also but just under the 200d now. Nice 3.96% div.
- Roadrunner: $ABBV sitting on 50 day weekly - hasn't dropped below that since late 2020 - looks like a double bottom on the daily - up 3% today
- sgiseller: $MRK $LLY $ABBV starting very small positions in all
- Margi1983: $ABBV. Sitting at the 50..Volatility squeeze... Profitable, good sales growth, good earnings growth, 3.8% Divi. What's not to like? NP but watching
-
DAN: ...
$ABBV -- Watch at $155. Alert $155
Solar Flares -- All were day trader’s delight.
$TAN -- Long handled hammer. Key reversal pattern.
$ENPH -- dragonfly doji? Long handled hammer? This is a high volume reversal pattern with lots of supply ... - Mikev200: $ABBV stop raised to lod
- Mikev200: $ABBV trailers up. Now @ yesterday high. Unless the market takes off, I don't see this blowing past the 50dma.
- Mikev200: $ABBV small add from yesterday small start
- Kid2old: @Mikev200 $ABBV Also have a small position in $ABBV. Watching $LLY $JNJ $MRK $PFE.
- Mikev200: @scottrades $BMY Been watching for some time, got in 5/11 small and small add yesterday. $ABBV add small, I 'll sell @ 50 unless blows past or stop is hit
- Mikev200: $ABBV polite move up from drop on 4/29, gap filled. Starter today under $155. resistance @50dma.
- Pokersmith: #IBD #fwiw AbbVie $ABBV plummeted more than 8% in heavy volume, gapping below the 50-day moving average. That marks a sell signal for the health care leader. The drugmaker is on pace for its worst single-day loss since March 16, 2020, when it fell 13%, according to Dow Jones Market Data. AbbVie cut its 2022 forecast and gave a mixed first-quarter report. Prior to today's sell-off, the stock was acting right, holding above the 50-day line. " cut its 2022 forecast" and vertical violation AND market in correction = No bueno 👎
- woodman: $VRTX - #Biotech has been the Market's Mudville for some time - a place where no joy is found. But Mudville doesn't have $VRTX which has been a sunny patch among dark clouds. Getting a lift today on bad news for $ABBV's Cystic Fibrosis drug.
- Mikev200: $ABBV earning today/big drop....buyers now!?
- Hackberry: @Mikev200 $ABBV I am looking for a 50 weekly entry around 125-130, but it may not get there.
- Mikev200: @Hackberry $ABBV For sure, earlier I thought the same, maybe 50 week start a base. Now, I see it held the 20 week. One thing I know, I'm in no hurry :)
- woodman: @Mikev200 $ABBV - I mentioned this morning that $VRTX was moving higher because ABBV had bad results on its Cystic Fibrosis drug.
- Mikev200: @woodman $ABBV Yes, saw that. They could make a ton a cash just by cutting down in TV commercials! LOL soooo many.
- Pokersmith: @Mikev200 $ABBV this is a no touch till further notice. If you HAVE to buy some, be patient and wait for it to make a proper set up. That said...no trade could be your best trade right now. #discipline
- Cjauger: @Mikev200 $ABBV was bought into the close
- Mikev200: $ABBV back above 50dma and earnings tomorrow, BMO
- scottrades: Just a reminder, Big Earnings Week still in store.. $FB $AAPL $MSFT $AMZN $PYPL $GOOGL $KO $UPS $ATVI $TWTR $XOM $BA $F $GE $SPOT $PEP $ROKU $MMM $CVX $QCOM $VLO $RTX $CL $INTC $JBLU $V $WM $CAT $NOK $LUV $GM $DHI $HOOD $ENPH $CVE $MA $ABBV $OTIS $PHG $CMG $MCD $MRK $DORM $X $ADM
- Cjauger: @scottrades $XLU thoughts on $ABBV and $COST?
- Mikev200: $ABBV trim @ HOD/ earnings Friday
- Cjauger: $ABBV bouncing from the 50 day. @scottrades thoughts? Started a small position
- Mikev200: @Cjauger $ABBV Not @scottrades, keep in mind earnings are Friday bmo
- Cjauger: @Mikev200 $ABBV thank you
- Mikev200: $ABBV watching for a 50dma close to hold, earnings next week.
- Pokersmith: @Mikev200 $ABBV ha ! Was just looking at it. Tempted, but earnings too close...and this market is in a corrective mood
- Mikev200: @Pokersmith $ABBV I have a bit so I'll keep as long as it keeps holding that 50.
- Pokersmith: Has anyone else noticed that $ABBV pulled back to its 50 day and held serve? ?
- maracom: @Pokersmith $ABBV post dividend dump, reminds me of $ZIM
| Stock Price | $175.58 |
| Change | 2.37% |
| Volume | 18,938,300 |
AbbVie Inc is a research-based biopharmaceutical company. Its products are used to treat diseases including rheumatoid arthritis, psoriasis, Crohn's disease, HIV, cystic fibrosis complications.
Request Video of ABBVAlready a member? Sign in here.
Past Month
Leading Peers
-
$20.23 36.81%
-
$22.09 25.84%
-
$5.07 11.93%
Past Month
Lagging Peers
-
$6.48 -27.02%
-
$34.22 -24.89%
-
$10.89 -18.02%
Dan Fitzpatrick
Stock Market Mentor gives you EVERYTHING you need to succeed in the market; all in one place. How easy is that? Dan Fitzpatrick and his elite community of traders share trading ideas, strategies and much more. Dan Fitzpatrick--a world class Technical Analyst, trading coach and regular CNBC contributor--gives you access to all of this with a 30 day trial membership for just $7.77. Get started TODAY and start trading better TOMORROW with the following premium content:
- Nightly video Strategy Sessions with a game plan for tomorrow
- Got a stock you want Dan to look at? Just ask.
- Patent pending video alerts instantly delivered to you when one of Dan’s trading signals is triggered. This is not your typical price alert. This is a short video explaining the action you need to take to make money. No more “Woulda, coulda, shoulda”
- Access to over 90,400 stock analysis videos
- Access an ever expanding library (90,400) of educational videos that will save you time and make you money
Join a team of friends and traders that have one thing in common; a burning desire to succeed.
Become a Member Today!
Gain immediate access to all our exclusive articles, features, how-to's, discussion group and much more...
Satisfaction Guaranteed!
Your Stock Market Mentor membership comes with a 30 day, no questions asked, 100% money back guarantee!